Afrezza® INHALE-1 Study in Pediatrics

PHASE3CompletedINTERVENTIONAL
Enrollment

319

Participants

Timeline

Start Date

September 29, 2021

Primary Completion Date

October 3, 2024

Study Completion Date

April 29, 2025

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
BIOLOGICAL

Afrezza

"Pharmaceutical form: powder~Route of administration: inhalation"

BIOLOGICAL

Rapid-acting Insulin Analog

"Pharmaceutical form: clear and colorless solution for injection~Route of administration: subcutaneous"

BIOLOGICAL

Basal Insulin

"Pharmaceutical form: solution for injection~Route of administration: subcutaneous"

Trial Locations (39)

10016

NYU Langone, Hassenfeld Children's Hospital, New York

14203

UBMD Pediatrics Buffalo, Buffalo

19104

Children's Hospital of Philadelphia, Philadelphia

19803

Nemours Children's Hospital, Delaware, Wilmington

21229

Dr. Barry J. Reiner, Baltimore

21287

Johns Hopkins University, Baltimore

23298

Virginia Commonwealth University, Richmond

30329

Emory University, Children's Healthcare of Atlanta, Atlanta

32610

University of Florida, Gainesville

32803

Advent Health Orlando, Orlando

33021

Joe DiMaggio Children's Hospital, Hollywood

33612

University of South Florida, Tampa

38133

AM Diabetes and Endocrinology Center, Bartlett

40202

University of Louisville, Norton Children's Hospital, Louisville

44106

University Hospitals Cleveland Medical Center, Cleveland

45229

Cincinnati Children's Hospital, Cincinnati

46202

Indiana University, Indianapolis

48152

Michigan Pediatric Endocrine and Diabetes Services, Livonia

50265

Iowa Diabetes Research, IDR, West Des Moines

52242

University of Iowa, Iowa City

53201

Medical College of Wisconsin, Milwaukee

55455

University of Minnesota, Minneapolis

64111

Children's Mercy Hospital, Kansas City

73104

Oklahoma Children's Hospital, Oklahoma City

75390

UT Southwestern, Dallas

78229

Diabetes & Glandular Disease Clinic, DGD, San Antonio

78539

DHR Health, Edinburg

83404

Rocky Mountain Clinical Research, Idaho Falls

89113

The DOCS, Las Vegas

90027

Children's Hospital Los Angeles, Los Angeles

92123

University of California San Diego, Rady Children's Hospital, San Diego

92868

Children's Hospital of Orange County, Orange

94158

University of California San Francisco, San Francisco

94304

Stanford University, Palo Alto

95821

Sutter Institute for Medical Research (formerly Center of Excellence in Diabetes and Endocrinology), Sacramento

98105

Seattle Children's, Seattle

06511

Yale New Haven Hospital, New Haven

02215

Joslin Diabetes Center, Boston

07960

Atlantic Health, Morristown

Sponsors
All Listed Sponsors
collaborator

Jaeb Center for Health Research

OTHER

lead

Mannkind Corporation

INDUSTRY